Prostate Cancer Targeting by Replication-Selective Adenoviral Mutants: Combination Treatments with Phytochemical Drugs

被引：0
|
作者：
Adam, Virginie [1 ]
Oberg, Daniel [1 ]
Lemoine, Nick [1 ]
Hallden, Gunnel [1 ]
机构：
[1] Barts & London Queen Marys Sch Med & Dent, CR UK Clin Ctr, Ctr Mol Oncol & Imaging, Inst Canc, London, England
来源：
MOLECULAR THERAPY | 2009年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [41] Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells
    Watanabe, T
    Hioki, M
    Fujiwara, T
    Nishizaki, M
    Kagawa, S
    Taki, M
    Kishimoto, H
    Endo, Y
    Urata, Y
    Tanaka, N
    Fujiwara, T
    EXPERIMENTAL CELL RESEARCH, 2006, 312 (03) : 256 - 265
  • [42] Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity
    Nemunaitis, J
    Cunningham, C
    Buchanan, A
    Blackburn, A
    Edelman, G
    Maples, P
    Netto, G
    Tong, A
    Randlev, B
    Olson, S
    Kirn, D
    GENE THERAPY, 2001, 8 (10) : 746 - 759
  • [43] MCL1 inhibitor drives prostate cancer cell apoptosis in combination with mitochondria-targeting drugs
    Ohtsu, Akira
    Arai, Seiji
    Sawada, Tatsuhiro
    Suzuki, Kazuhiro
    CANCER SCIENCE, 2021, 112 : 668 - 668
  • [44] A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer
    Small, Eric J.
    Carducci, Michael A.
    Burke, James M.
    Rodriguez, Ron
    Fong, Lawrence
    van Ummersen, Lynn
    Yu, D. C.
    Aimi, Junko
    Ando, Dale
    Working, Peter
    Kirn, David
    Wilding, George
    MOLECULAR THERAPY, 2006, 14 (01) : 107 - 117
  • [45] Novel drugs targeting the androgen receptor pathway in prostate cancer
    Mateo, Joaquin
    Smith, Alan
    Ong, Michael
    de Bono, Johann S.
    CANCER AND METASTASIS REVIEWS, 2014, 33 (2-3) : 567 - 579
  • [46] Novel drugs targeting the androgen receptor pathway in prostate cancer
    Joaquin Mateo
    Alan Smith
    Michael Ong
    Johann S. de Bono
    Cancer and Metastasis Reviews, 2014, 33 : 567 - 579
  • [47] Targeting prostate cancer cells with neurotransmission modulating drugs.
    Hegele, Axel
    Heers, Hendrik
    Urbschat, Anja
    Di Fazio, Pietro
    Weihe, Eberhard
    Kinscherf, Ralf
    Hofmann, Rainer
    Haenze, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization
    Mukha, Anna
    Kahya, Ugur
    Dubrovska, Anna
    AUTOPHAGY, 2021, 17 (11) : 3879 - 3881
  • [49] A phase 1/11 trial of IVCG7870, a replication-selective, PSA-targeted oncolytic adenovirus (OAV), for the treatment of hormone-refractory, metastatic prostate cancer
    Wilding, G
    Carducci, M
    Yu, DC
    Burke, J
    Borellini, F
    Aimi, J
    Working, P
    Ando, D
    Kirn, D
    Small, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 204S - 204S
  • [50] Virus-mediated oncolysis of thyroid cancer by a replication-selective adenovirus driven by a thyroglobulin promoter-enhancer region
    Kesmodel, S
    Prabakaran, I
    Canter, R
    Menon, C
    Molnar-Kimber, K
    Fraker, D
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06): : 3440 - 3448
12345